RevOpsis Therapeutics, Inc. — Form D
RevOpsis Therapeutics, Inc. of SPRINGFIELD, IL, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-10. The offering totals $7.9M, of which $7.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-10
- Form: D
- Accession: 0001939796-23-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $7.9M
- Amount sold: $7.9M
- Minimum investment: $25K
- Investors: 36
- Date of first sale: 2023-07-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-489317
Issuer
- Name: RevOpsis Therapeutics, Inc.
- CIK: 0001939796
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 4109 CHANDLERWOOD, SPRINGFIELD, IL, 62711
- Phone: 6462215178
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ramanath Bhandari | Director | Tampa, FL |
| Ram Palanki | Director | Tampa, FL |
| Ram Palanki | Executive Officer | Tampa, FL |
| Jeff Olson | Director | Tampa, FL |
| Ramanath Bhandari | Executive Officer | Tampa, FL |
| Ramanath Bhandari | Promoter | Tampa, FL |
| Jeff P Olson | Director | Springfield, IL |
| Ram P Palanki | Director | Springfield, IL |
| Ram P Palanki | Executive Officer | Springfield, IL |
Other filings by this issuer (3)
More